China Health Group Limited

Symbol: 0673.HK

HKSE

1.08

HKD

Market price today

  • -7.1901

    P/E Ratio

  • 0.1252

    PEG Ratio

  • 517.31M

    MRK Cap

  • 0.00%

    DIV Yield

China Health Group Limited (0673-HK) Stock Price & Analysis

Shares Outstanding

479M

Gross Profit Margin

0.32%

Operating Profit Margin

-0.30%

Net Profit Margin

-0.53%

Return on Assets

-0.16%

Return on Equity

-0.78%

Return on Capital Employed

-0.14%

Company general description and statistics

Sector: Healthcare
Industry: Medical Distribution
CEO:Mr. Ho Chung
Full-time employees:137
City:Central
Address:China Insurance Group Building
IPO:1996-10-14
CIK:

China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables, and operation and management of hospitals in the People's Republic of China. It is also involved in business factoring business, as well as property investment business. The company was formerly known as China HealthCare Holdings Limited and changed its name to China Health Group Limited in September 2015. The company is headquartered in Central, Hong Kong.

General Outlook

In simple terms, China Health Group Limited has 478.995 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.321% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.300%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.535%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.155% return, is a testament to China Health Group Limited's adeptness in optimizing resource deployment. China Health Group Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.782%. Furthermore, the proficiency of China Health Group Limited in capital utilization is underscored by a remarkable -0.137% return on capital employed.

Stock Prices

China Health Group Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.09, while its low point bottomed out at $1.03. This variance in figures offers investors a lucid insight into the roller-coaster ride that is China Health Group Limited's stock market.

Liquidity Ratios

Analyzing 0673.HK liquidity ratios reveals its financial health of the firm. The current ratio of 102.10% gauges short-term asset coverage for liabilities. The quick ratio (59.72%) assesses immediate liquidity, while the cash ratio (2.43%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio102.10%
Quick Ratio59.72%
Cash Ratio2.43%

Profitability Ratios

0673.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -48.58% underscores its earnings before tax deductions. The effective tax rate stands at -0.45%, revealing its tax efficiency. The net income per EBT, 110.10%, and the EBT per EBIT, 161.95%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -30.00%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-48.58%
Effective Tax Rate-0.45%
Net Income per EBT110.10%
EBT per EBIT161.95%
EBIT per Revenue-30.00%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.02, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding60
Days of Inventory Outstanding71
Operating Cycle333.30
Days of Payables Outstanding129
Cash Conversion Cycle204
Receivables Turnover1.39
Payables Turnover2.83
Inventory Turnover5.13
Fixed Asset Turnover4.61
Asset Turnover0.29

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.05, and free cash flow per share, -0.05, depict cash generation on a per-share basis. The cash per share value, 0.01, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.22, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.05
Free Cash Flow per Share-0.05
Cash per Share0.01
Operating Cash Flow Sales Ratio-0.22
Free Cash Flow to Operating Cash Flow Ratio1.06
Cash Flow Coverage Ratio-3.47
Short Term Coverage Ratio-3.47
Capital Expenditure Coverage Ratio-16.89
Dividend Paid and Capex Coverage Ratio-16.89

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 1.82%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.09, we discern the balance between debt and equity financing. An interest coverage of -13.82 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio1.82%
Debt Equity Ratio0.09
Total Debt to Capitalization8.14%
Interest Coverage-13.82
Cash Flow to Debt Ratio-3.47
Company Equity Multiplier4.88

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -100.00%, indicates top-line expansion, while the gross profit growth, -100.00%, reveals profitability trends. EBIT growth, 100.00%, and operating income growth, 100.00%, offer insights into operational profitability progression. The net income growth, 100.00%, showcases bottom-line expansion, and the EPS growth, 100.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-100.00%
Gross Profit Growth-100.00%
EBIT Growth100.00%
Operating Income Growth100.00%
Net Income Growth100.00%
EPS Growth100.00%
EPS Diluted Growth100.00%
Weighted Average Shares Growth3.48%
Weighted Average Shares Diluted Growth3.48%
10-Year Revenue Growth per Share-100.00%
5-Year Revenue Growth per Share-100.00%
3-Year Revenue Growth per Share-100.00%
10-Year Net Income Growth per Share-100.00%
5-Year Net Income Growth per Share100.00%
3-Year Net Income Growth per Share100.00%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.45, and the price to book ratio, 5.45, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.90, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -17.02, and price to operating cash flows, -17.77, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio5.45
Price to Book Ratio5.45
Price to Sales Ratio3.90
Price Cash Flow Ratio-17.77
Price Earnings to Growth Ratio0.13
Enterprise Value Multiple-15.81
Price Fair Value5.45
Price to Operating Cash Flow Ratio-17.77
Price to Free Cash Flows Ratio-17.02
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of China Health Group Limited (0673.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -7.190 in 2024.

What is the ticker symbol of China Health Group Limited stock?

The ticker symbol of China Health Group Limited stock is 0673.HK.

What is company IPO date?

IPO date of China Health Group Limited is 1996-10-14.

What is company current share price?

Current share price is 1.080 HKD.

What is stock market cap today?

The market cap of stock today is 517314609.000.

What is PEG ratio in 2024?

The current 0.125 is 0.125 in 2024.

What is the number of employees in 2024?

In 2024 the company has 137.